S&P/ASX 200 Index (ASX: XJO) lithium shares have delivered some stellar returns over the past year.

But the last few weeks have left some investors wondering if the party is coming to an end for the big lithium companies.

What’s been happening with the big lithium stocks?

In November, only two of the five ASX 200 lithium shares posted gains, while the benchmark index leapt 6.1% higher over the month.

This was despite several of the miners hitting new all-time highs earlier in the month amid record prices for the battery-critical metal. Then lithium prices began to slide.

Now, as we approach the end of the third day of trading in December, it looks like the selling trend from the past few weeks may be reversing. At least for some.

Here’s how the top ASX 200 lithium shares have performed since the closing bell on 30 November:

• Core Lithium Ltd (ASX: CXO) shares are down 2.1%
• Allkem Ltd (ASX: AKE) shares are up 4.6%
• Pilbara Minerals Ltd (ASX: PLS) shares have gained 1.3%
• IGO Ltd (ASX: IGO) shares are up 2.9%
• Mineral Resources Ltd (ASX: MIN) shares have gained 4.3%

For some context, the ASX 200 is up 0.7% over this same period.

Can ASX 200 lithium shares come charging back in December?

With the exception of Mineral Resources – hands down the best-performing ASX 200 lithium share in November with a 19.5% share price gain – the rest of the pack struggled with a dip in lithium prices.

Most of that’s been due to some headwinds blowing out of China, the world’s biggest electric vehicle (EV) producer.

China’s economy-hampering COVID zero policies have given some investors in lithium stocks the jitters. Especially as infection numbers in the nation soared and rare anti-government protests broke out across major cities.

2023 is also likely to see the Chinese government axe its subsidies to domestic battery manufacturers. And the government has flagged an end to rebates for consumers purchasing new EVs.

Add to that reports that Chinese battery manufacturers look to have overproduced the near-term needs of EV manufacturers and you can see why lithium prices, and ASX 200 lithium shares, have come under pressure recently.

Which brings us back to the outlook for December.

China may well end its EV subsidies and there may be some short-term battery oversupply issues making the news this month. In turn, this could put some pressure on the big lithium stocks.

However, over the weekend, the Chinese government did an extraordinary backflip on its pandemic containment policies.

While some restrictions remain, officials have bowed to protester demands and are turning their attention more towards growing the economy than stamping out the virus.

An end (or near-end) to lockdowns should offer a healthy boost to China’s mammoth manufacturing sector. And we suspect this will also see more analysts upgrading their near-term forecasts for lithium demand.

Which could mean good news for ASX 200 lithium shares in December.

The post Can ASX 200 lithium shares come charging back in December? appeared first on The Motley Fool Australia.

(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}

setButtonColorDefaults(“#0095C8”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#0095C8”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()

More reading

• Why Arafura, Mayne Pharma, Pilbara Minerals, and Tyro shares are dropping today
• Here are the 3 most heavily traded ASX 200 shares on Monday
• Why is the Pilbara Minerals share price sinking deep into the red today?
• 2 ASX lithium shares smashing all-time highs on Monday
• ASX index beaters: 5 shares that have supercharged portfolios in 2022

from The Motley Fool Australia https://ift.tt/MTacH4G

The Mesoblast Ltd (ASX: MSB) share price has been on a top run lately. It’s launched 25% higher over the last 30 days.

Indeed, this time last month, shares in the clinical-stage biotechnology company were trading for 92 cents. Today, the Mesoblast share price is $1.16.

For comparison, the All Ordinaries Index (ASX: XAO) has risen 6% over the last month.

So, what’s been bolstering the Mesoblast share price lately? Let’s take a look.

What’s been going right for the Mesoblast share price lately?

Mesoblast has had a good run recently. That’s despite the market appearing disappointed by the only price-sensitive news from the company.

The healthcare company released its latest quarterly update and news of a key trial on 24 November. That same day, the Mesoblast share price slipped 1%.

Over the September quarter, Mesoblast burnt through US$14.3 million and brought in US$1.4 million of revenue. Though, there was more positive news released alongside its earnings.

Mesoblast also revealed the long-term survival results for its remestemcel-L phase 3 trial in children with steroid-refractory acute graft-versus-host disease (SR-aGVHD).

Overall survival at two years for children treated with the drug was 51% compared to between 25% and 38% in recent studies of children or adults treated with the best available therapy.

The company’s chair Joseph Swedish said the results reaffirmed the potential significance of the drug as “ a life-saving treatment for children with SR-aGVHD”.

Mesoblast CEO Dr Silviu Itescu also commented:

These substantial and durable long-term survival outcomes seen in our Phase 3 trial with remestemcel-L are a cornerstone to our [Biologics License Application] resubmission.

That same day the company hosted its annual general meeting (AGM). There, Swedish reiterated the company is hoping to see regulators give remestemcel-L their tick of approval in the first half of 2023.

Mesoblast is also working to get its rexlemestrocel-L to market as a treatment for chronic low back pain associated with degenerative disc disease and for heart failure with reduced ejection fraction.

Interestingly, the biggest gain posted by the Mesoblast share price over the period was on a day of seeming silence. The stock soared 11.6% on Wednesday last week despite no word from the company.

The post Why has the Mesoblast share price boomed 25% in a month? appeared first on The Motley Fool Australia.

(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}

setButtonColorDefaults(“#0095C8”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#0095C8”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()

More reading

• What’s going on with the Mesoblast share price today?
• Why did the Mesoblast share price soar 9% today?

Motley Fool contributor Brooke Cooper has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/TNtjCSJ

The S&P/ASX 200 Index (ASX: XJO) is on course to start the week in a positive fashion. In afternoon trade, the benchmark index is up 0.5% to 7,340.4 points.

Four ASX shares that have failed to follow the market higher today are listed below. Here’s why they are dropping:

Arafura Rare Earths Ltd (ASX: ARU)

The Arafura share price is down 5.5% to 41.5 cents. This has been driven by the company’s institutional placement. The rare earths developer has received firm commitments for a $121 million placement to accelerate the Nolans Project development schedule. These funds are being raised at a 15.9% discount of 37 cents per new share.

Mayne Pharma Group Ltd (ASX: MYX)

The Mayne Pharma share price is down over 10% to 21.5 cents. This morning the pharmaceutical company announced that it has signed a transaction agreement and related license agreement for a portfolio of on-market women’s health products from TherapeuticsMD for US$140 million. The products’ net revenue in the third quarter of 2022 were US$20.9 million and gross profit was US$17.1 million.

Pilbara Minerals Ltd (ASX: PLS)

The Pilbara Minerals share price is down 4.5% to $4.64. This is despite the lithium giant being added to the ASX 50 index at the quarterly rebalance. Investors appear to have concerns about lithium prices following a couple of bearish broker notes and news of a new major lithium mine development.

Tyro Payments Ltd (ASX: TYR)

The Tyro share price is down 5.5% to $1.62. Investors have been selling this payments company’s shares following the release of a transaction update. According to the release, transaction value growth slowed to 16% during the month of November. This is a sharp slowdown compared to its year to date growth rate of 43%.

The post Why Arafura, Mayne Pharma, Pilbara Minerals, and Tyro shares are dropping today appeared first on The Motley Fool Australia.

(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}

setButtonColorDefaults(“#0095C8”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#0095C8”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()

More reading

• Here are the 3 most heavily traded ASX 200 shares on Monday
• Why is the Pilbara Minerals share price sinking deep into the red today?
• ASX index beaters: 5 shares that have supercharged portfolios in 2022
• Arafura share price sinks 12% as Gina buys up big
• Why is the Pilbara Minerals share price charging higher on Monday?

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Tyro Payments. The Motley Fool Australia has recommended Tyro Payments. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/Uqzj0wd

The S&P/ASX 200 Index (ASX: XJO) has kicked off the trading week on a positive note so far this Monday. After recording a gain last week, the ASX 200 is once again living up to the fabled December ‘Santa rally’ and is lifting higher at this point of the session.

At the time of writing, the index has gained a healthy 0.49%, lifting the index up to just under 7,340 points.

So time now to dive deeper into these market moves by having a look at the shares currently topping the ASX 200’s share trading volume charts, according to investing.com.

The 3 most traded ASX 200 shares by volume this Monday

South32 Ltd (ASX: S32)

First up today is the mining giant South32. This Monday has had a sizeable 16.7 million South32 shares bounce around the markets today so far. There’s been no fresh news out of South32 so far this week.

However, the South32 share price has really taken off today. The miner is currently enjoying a 4.06% lift to $4.36 a share. Most ASX resources shares are taking flight today following some pleasing price rises on the commodity markets. It’s this gain that is likely leading these volume figures.

Core Lithium Ltd (ASX: CXO)

ASX 200 lithium share Core Lithium is our next share for today. This lithium producer had had a hefty 19.82 million shares change hands as it currently stands. There’s been no new news out of Core shares either today. But investors are sending this company in the opposite direction to South32 regardless.

Like most ASX lithium shares today, the Core Lithium share price has lost a painful 3.65% of its value so far today, putting it down to $1.32 a share. It’s not quite clear what’s up with lithium today, but this drop is probably the cause of the high volumes on display.

Pilbara Minerals Ltd (ASX: PLS)

Speaking of the devil, our last ASX 200 share worth taking a gander at today is Core’s fellow lithium luminary Pilbara Minerals. A whopping 25.03 million Pilbara shares have been bought and sold thus far this session.

The same factors seem to be at play here. However, investors have decided to punish Pilbara even more harshly than Core, with this company currently down a nasty 4.32% at $4.65 a share. Again, it’s this selling pressure that is likely influencing the high volumes we are seeing.

The post Here are the 3 most heavily traded ASX 200 shares on Monday appeared first on The Motley Fool Australia.

(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}

setButtonColorDefaults(“#0095C8”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#0095C8”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()

More reading

• Why is the Pilbara Minerals share price sinking deep into the red today?
• ASX index beaters: 5 shares that have supercharged portfolios in 2022
• Could Core Lithium shares be set for a Santa rally in December?
• Guess which gold share is being booted out of the ASX 200
• With almost no savings at 30, I’d use the Warren Buffett method to try to get rich!

Motley Fool contributor Sebastian Bowen has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/UfsncGr

Building up a passive income stream is no easy feat. Having money pouring into your bank account with no labour or effort required is the dream. But it is easier to dream than do.

Luckily for would-be passive income earners, shares are an ideal investment vehicle to help you build up passive income and move closer toward financial independence. Not only do many ASX shares pay dividends (a form of passive income), but many also issue franking credits as well, which can also help to boost your income even further.

$20 a week is a reasonable target for most Australians to invest each week. Hopefully, that won’t have a meaningful impact on a standard of living and can be repeated each week.

$20 a week equates to roughly $80 a month, or more accurately, $1,040 a year.

How to get passive income from ASX dividend shares (or ETFs)

If I wished to build up a passive income stream from ASX shares, the first investment I would look to is an exchange-traded fund (ETF) specialising in dividend income. One such fund is the Vanguard Australian Shares High Yield ETF (ASX: VHY).

This ETF deliberately targets a stream of passive dividend income for its investors. It does so by only holding high-yielding ASX dividend shares in its portfolio, from which it can pass income and franking onto its investors.

Some of its current top holdings include dividend beasts like BHP Group Ltd (ASX: BHP), Woodside Energy Group Ltd (ASX: WDS) and National Australia Bank Ltd (ASX: NAB).

So over the past 12 months, this Vanguard ETF has forked out distributions worth a total of $3.84 per share. At today’s unit price of $69.28 (at the time of writing) for the Vanguard Australian Shares High Yield ETF, that gives it a healthy distribution yield of 5.54%.

It’s worth mentioning here that Vanguard ETFs offer zero brokerage fees and a low minimum investment amount. Other ASX share investments will differ, so be mindful of regular brokerage fees potentially impacting your returns.

By the numbers…

If we invested $20 a week in the Vanguard Australian Shares High Yield ETF for a whole year, a hypothetical investor could pull around $57.62 in dividend income by the end of the year. If that investor spent 10 years putting $20 a week away, this would rise to $576.20 in dividend income per year. That would be $1,152.40 a year after 20 years.

If our investor reinvested their dividends each year, this would get a boost up to approximately $1,212.97 in dividend income per year.

Of course, this assumes that the dividend distributions from the high-yield Vanguard ETF remain the same over this two-decade period, which is highly unlikely.

Chances are that this 20-year period will see the annual distributions from this ETF increase substantially as well, leaving our investor with even more passive income.

That’s enough to make a meaningful difference to a retirement.

The post How I’d build passive income with just $20 a week appeared first on The Motley Fool Australia.

(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}

setButtonColorDefaults(“#0095C8”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#0095C8”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()

More reading

• Buy these ETFs for an income in retirement

Motley Fool contributor Sebastian Bowen has positions in National Australia Bank. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Vanguard Australian Shares High Yield ETF. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/NAekdbq

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to start the week with a solid gain. At the time of writing, the benchmark index is up 0.5% to 7,340.4 points.

Four ASX shares that are climbing more than most today are listed below. Here’s why they are pushing higher:

Imugene Limited (ASX: IMU)

The Imugene share price up 1.5% to 18.75 cents. This follows the release of two updates this morning. One revealed that the first patient has been dosed with the novel cancer-killing virus Vaxinia as part of the intravenous cohort 2 trial.

Rio Tinto Ltd (ASX: RIO)

The Rio Tinto share price is up 4% to $116.20. Investors have been buying Rio Tinto and other ASX iron ore miners after the price of the steel making ingredient charged higher. The spot iron ore price is now nearing US$110 a tonne. This is up from approximately US$80 a tonne at the start of November. The potential reopening of China appears to be behind this rise.

Santos Ltd (ASX: STO)

The Santos share price is up 3% to $7.35. This appears to have been driven by a rise in oil prices during Asian trade. Prices have climbed after OPEC announced that it will push ahead with its plans to cut production by 2 million barrels per day in 2023. China easing COVID restrictions also appears to be supporting prices.

Warrego Energy Ltd (ASX: WGO)

The Warrego Energy share price is up 12% to 31.7 cents. This follows news that Hancock Energy has increased its takeover bid from $0.23 per Warrego share to $0.28 per Warrego share. All other terms of its offer remain unchanged. Beach Energy Ltd (ASX: BPT) has been given five business days to match the revised Hancock Energy takeover offer.

The post Why Imugene, Rio Tinto, Santos, and Warrego shares are pushing higher appeared first on The Motley Fool Australia.

(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}

setButtonColorDefaults(“#0095C8”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#0095C8”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()

More reading

• Warrego Energy share price leaps 12% as takeover battle continues
• Why did the Rio Tinto share price rocket 24% in November?
• The iron ore price just posted its biggest-ever monthly gain. What’s going on?
• 5 things to watch on the ASX 200 on Monday
• 3 best-performing ASX 200 energy shares in November

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/q83chLT

The Pilbara Minerals Ltd (ASX: PLS) share price has given back its morning gains and dropped deep into the red.

In afternoon trade, the lithium miner’s shares are down 5.5% to $4.59.

Why is the Pilbara Minerals share price falling?

This morning the Pilbara Minerals share price was charging higher in response to news that the lithium miner will be added to the ASX 50 index at the next rebalance.

However, it has now given back those gains and more this afternoon after investors suddenly hit the sell button en masse.

Pilbara Minerals isn’t alone in trading in the red today. There are a number of other ASX lithium shares trading notably lower on Monday along with it. For example, the Allkem Ltd (ASX: AKE) share price is down almost 2%, the Core Lithium Ltd (ASX: CXO) share price is down 4%, and the Liontown Resources Ltd (ASX: LTR) share price is down 2%.

What’s going on?

It remains unclear why the Pilbara Minerals share price has come under pressure this afternoon.

Though, it is worth noting that this weekend there were reports of new lithium mines coming into operation in the near future.

According to the Financial Times, Sigma Lithium has announced that it will start commissioning the Grota do Cirilo project in Minas Gerais state this month and aims to be shipping lithium by the end of April.

After which, by 2024 it plans to almost triple its targeted annual output to approximately 100,000 tonnes of lithium carbonate equivalent (LCE). This will make it a top four global producer.

It’s possible that some investors believe this increase in supply could put downward pressure on lithium prices. However, you could argue that given how strong demand is, this increased supply would likely be gobbled up very quickly by end users.

In light of this, investors may want to stay tuned for the next BMX auction from Pilbara Minerals to see how lithium prices are faring at present. One could be coming very soon based on when previous auctions were held.

The post Why is the Pilbara Minerals share price sinking deep into the red today? appeared first on The Motley Fool Australia.

(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}

setButtonColorDefaults(“#43B02A”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#43B02A”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()

More reading

• ASX index beaters: 5 shares that have supercharged portfolios in 2022
• Why is the Pilbara Minerals share price charging higher on Monday?
• 5 things to watch on the ASX 200 on Monday
• Can the Pilbara Minerals share price regain its lustre in December?
• Here are the 3 most heavily traded ASX 200 shares on Friday

Motley Fool contributor James Mickleboro has positions in Allkem. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/8okLKW5

The CSL Limited (ASX: CSL) share price leapt 7% in November, and December looks like it could bring more joy. Experts are generally bullish on the Aussie biotechnology giant.

Particularly on the back of the company’s Hemgenix treatment, which recently received US Food and Drug Administration (FDA) approval. The gene therapy is designed to treat hemophilia B.

It has also reportedly been crowned the world’s most expensive treatment. A single dose is said to command a US$3.5 million price tag.

Right now, the CSL share price is $299.72.

Let’s take a look at what brokers are saying about the S&P/ASX 200 Index (ASX: XJO) healthcare giant.

What might the future hold for the CSL share price?

CSL appears to be a favourite among brokers and experts right now, with some predicting its share price to leap as high as $343.

That’s the prediction put forward by Macquarie, as my Fool colleague James reports. The top broker has a buy rating on the stock and expects Hemgenix’s early 2023 launch to boost the company’s earnings.

Citi is also hopeful for CSL, slapping the share with a buy rating and a $340 price target.

Not all brokers are so enthusiastic, however. Goldman Sachs’ most recent forecast, from early November, tips the CSL share price to fall to $291.

It’s worth noting that experts apparently aren’t tipping the company’s bottom line to be immediately buoyed by Hemgenix’s launch. Indeed, CSL chief commercial officer Bill Campbell recently told investors “it will take a little bit of time for questions to be answered in the commercial space”, the Australian Financial Review reports.

Looking beyond CSL and to the healthcare sector more broadly, Janus Henderson portfolio manager Andy Acker recently wrote, per Livewire:

[E]ven if major economies enter a recession in 2023, we believe the healthcare sector could offer investors some safe harbour. In the past, the sector has outperformed in the months leading up to and during economic downturns; the same could hold true again.

Additionally, Morgans equity analyst Anna Milne is said to like the prospects of the company’s Seqirus vaccine in the upcoming flu season and its recently-acquired Vifor iron deficiency therapy business. Morgans expects the CSL share price to lift to $327, according to Livewire.

All in all, many experts appear to believe December could be a good time to buy CSL stock ahead of an expected share price surge.

The post Is the CSL share price set to take off in December? appeared first on The Motley Fool Australia.

(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}

setButtonColorDefaults(“#0095C8”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#0095C8”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()

More reading

• Why CSL shares are this fundie’s top ASX 200 healthcare pick
• Why did the CSL share price leap 7% in November?
• ‘Buy it for 5 years’: Jun Bei Liu’s 3 best ASX shares for 2023
• ‘Back a winner’: Expert names his 3 best ASX shares for 2023
• 2 high quality blue chip ASX 200 shares named as buys by analysts

Citigroup is an advertising partner of The Ascent, a Motley Fool company. Motley Fool contributor Brooke Cooper has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended CSL. The Motley Fool Australia has recommended Macquarie Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/Zz7nuYh

Two ASX lithium shares are having a top run on the market today.

The Mineral Resources Ltd (ASX: MIN) and Winsome Resources Ltd (ASX: WR1) share prices have both hit their all-time highs to start the trading week.

It comes on a day the S&P/ASX 200 Materials Index (ASX: XMJ) is also climbing 1.95% at the time of writing.

Let’s take a look at these two ASX lithium shares in more detail.

Winsome Resources

Winsome Resources shares gained 7.6% at their peak today to record an all-time high of $1.345 per share. The company is exploring lithium in the James Bay region of Quebec, Canada. Winsome has not released any news to the market today.

However, on Friday, Winsome advised it has acquired a key stake in a critical minerals project. Winsome has agreed take over Sinomine’s interests in the Case Lake Project in Ontario, Canada. The project is currently owned by Canadian company Power Metals Corp. The site hosts high-grade deposits of lithium, tantalum, and cesium.

In mid-November, Winsome announced a $6.8 million capital raise for its lithium projects. Winsome’s shares soared by 134% in November, the most of any ASX mining share. The company’s shares are currently trading at $1.28 each, a gain of 2.4% on Friday’s closing price.

Mineral Resources

Mineral Resources has hit another all-time high today after also lifting on Friday. The company’s shares peaked at $92.44 each today, a jump of almost 3% on Friday’s closing price.

Mineral Resources is exploring lithium hydroxide. The compound is currently priced at US$85,000 a tonne on the London Metal Exchange. Mineral Resources converted 4,703 tonnes of lithium hydroxide in the first quarter of FY23.

Mineral Resources is also a major iron ore producer. Iron ore prices climbed another 1.5% to US$106.5 a tonne on Friday. It continues climbing today, up another 2.39% on the Singapore Exchange at last look.

The Mineral Resources share price is currently $90.78, still up 1.06% after coming down from its all-time high this morning.

The post 2 ASX lithium shares smashing all-time highs on Monday appeared first on The Motley Fool Australia.

(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}

setButtonColorDefaults(“#43B02A”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#43B02A”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()

More reading

• ASX index beaters: 5 shares that have supercharged portfolios in 2022
• The ASX 200 gained 6% in November. Here’s how these 3 ASX mining shares smashed those returns
• Why is the Mineral Resources share price rocking an all-time high today?
• Thank you Mr Powell! 7 ASX 200 shares cracking new 52-week highs on Thursday
• Can you guess which 3 ASX 200 lithium shares led the charge in November?

Motley Fool contributor Monica O’Shea has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/qdaXAix

Given how many shares to choose from on the ASX, it can be hard to decide which ones to buy. The good news is that brokers across the country are doing a lot of the hard work for you.

Three top ASX shares that leading brokers have named as buys this week are listed below. Here’s why they are bullish on them:

Coronado Global Resources Inc (ASX: CRN)

According to a note out of Macquarie, its analysts have retained their outperform rating on this coal miner’s shares with a trimmed price target of $3.10. Although Coronado is unlikely to achieve its guidance in FY 2022 due to poor weather, the broker remains positive thanks to strong metallurgical coal prices. The Coronado share price is trading at $2.00 on Monday afternoon.

Telstra Group Ltd (ASX: TLS)

A note out of Morgan Stanley reveals that its analysts have retained their overweight rating on this telco giant’s shares with an improved price target of $4.75. The broker is feeling positive on Telstra’s outlook thanks to the recent approval of a restructure. It notes that this means the company could unlock value by selling some of its infrastructure assets. Morgan Stanley suspects that a major share buyback could be undertaken if assets are sold off. The Telstra share price is fetching $4.01 on Monday.

Woodside Energy Group Ltd (ASX: WDS)

Analysts at Citi have retained their buy rating but trimmed their price target on this energy producer’s shares to $38.50. Citi was pleased with Woodside’s production growth plans for the coming years. And while it has cut its earnings guidance to reflect aspects of its guidance, it still expects some very big dividends in the near term. As a result, it retains its buy rating. The Woodside share price is trading at $36.49 this afternoon.

The post Leading brokers name 3 ASX shares to buy today appeared first on The Motley Fool Australia.

(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}

setButtonColorDefaults(“#0095C8”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#0095C8”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()

More reading

• Is the Woodside share price cheap following its recent dip?
• Buy Telstra and this ASX dividend share: experts
• 5 things to watch on the ASX 200 on Monday
• What happened with the Woodside share price in November?
• Here are 2 of the best ASX dividend shares to buy: Morgans

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has positions in and has recommended Telstra Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/NzKoZhI